Skip Navigation

European Heart Journal 2001 22(3):201-208; doi:10.1053/euhj.1999.2010
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rerkpattanapipat, P
Right arrow Articles by Kotler, M.N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rerkpattanapipat, P
Right arrow Articles by Kotler, M.N
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Sex and the heart: what is the role of the cardiologist?

P Rerkpattanapipat, M.S Stanek and M.N Kotlerf1

Division of Cardiology, Department of Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, U.S.A.

revised October 27, 1999; accepted November 2, 1999

Key Words: Sex, heart, coital death, drug-induced sexual dysfunction, impotence, sildenafil

f1 Correspondence: Morris N. Kotler, MD, Albert Einstein Medical Center, Division of Cardiology, Department of Medicine, 5401 Old York Road, Philadelphia, PA19141, U.S.A.

References

  1. Skinner, JS, Sexual relation, Pollock, MLSchmidt, DH, Heart disease and rehabilitation, IL, Human Kinetics, 1995, 367, 78
  2. Nemec ED, Mansfield L, Kennedy JW. Heart rate and blood pressure responses during sexual activity in normal males. Am Heart J. 1964;92:274–277
  3. Bohlen JG, Held JP, Sanderson O, Patterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med. 1984;144:1745–1748[Abstract/Free Full Text]
  4. Garcia-Barreto D, Sin-Chesa C, Rivas-Estany E, Nieto R, Hemdndez-Cafiero A. Sexual intercourse in patients who have had a myocardial infarction. J Cardiopulm Rehabil. 1986;6:324–328
  5. Hellerstein HK, Friedman EH. Sexual activity and the postcoronary patient. Arch Intern Med. 1970;125:987–999[Abstract/Free Full Text]
  6. Larson JL, McNaughton MW, Kennedy JW, Mansfield LW. Heart rate and blood pressure responses to sexual activity and a stair-climbing test. Heart Lung. 1980;9:1025–1030[Web of Science][Medline]
  7. Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol. 1995;75:835–837[CrossRef][Web of Science][Medline]
  8. Drory Y, Fisman EZ, Shapira I, Pines A. Ventricular arrhythmias during sexual activity in patients with coronary artery disease. Chest. 1996;109:922–924[Abstract/Free Full Text]
  9. Seidl A, Bullough B, Haughey B, Scherer Y. Understanding the effects of a myocardial infarction on sexual functioning: a basis for sexual counseling. Rehabil Nurs. 1991;16:255–264[Medline]
  10. Stein RA. The effect of exercise training on heart rate during coitus in the post-myocardial infarction patient. Circulation. 1977;55:738–740[Abstract/Free Full Text]
  11. Johnston B, Fletcher GF. Dynamic electrographic recording during sexual activity in recent post-myocardial infarction and revascularization patients. Am Heart J. 1979;98:736–741[CrossRef][Web of Science][Medline]
  12. Masini V, Romei E, Fiorella AT. Dynamic electrogram in normal subjects during sexual activity. G Ital Cardiol. 1980;10:1442–1448[Medline]
  13. Jackson G. Sexual intercourse and angina pectoris. Int Rehabil Med. 1981;3:35–37[Medline]
  14. Ueno M. The so-called coition death. Jpn J Leg Med. 1963;17:333–340
  15. Walbroehl GS. Sexual activity and the postcoronary patient. Am Fam Physician. 1984;29:175–177[Web of Science][Medline]
  16. Muller JE, Mittleman A, Maclure M, Sherwood JB, Tofler. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. J Am Med Assoc. 1996;275:1405–1409[Abstract/Free Full Text]
  17. Bloch A, Maeder JP, Haissly JC. Sexual problems after myocardial infarction. Am Heart J. 1975;90:536–537[CrossRef][Web of Science][Medline]
  18. Papadopoulos C, Beaumont C, Shelley SI, Larrimore P. Myocardial infarction and sexual activity of the female patient. Arch Intern Med. 1983;143:1528–1530[Abstract/Free Full Text]
  19. Johnston B, Cantwell J, Watt EW, Fletcher GF. Sexual activity in exercising patients after myocardial infarction and revascularization. Heart Lung. 1978;7:1026–1031[Web of Science][Medline]
  20. Singh J, Singh S, Singh S, Singh A, Malhotra RP. Sex life and psychiatric problems after myocardial infarction. J Assoc Physicians India. 1970;18:503–507[Medline]
  21. Abramov L. Sexual life and sexual frigidity among women developing acute myocardial infarction. Psychosom Med. 1976;38:418–425[Abstract/Free Full Text]
  22. Rahe RH, Ward HW, Hayes V. Brief group therapy in myocardial infarction rehabilitation: three-to-four-year follow-up of a controlled trial. Psychosom Me. 1979;41:229–242
  23. Stanek MS. Cardiovascular disease. Farber M. Human sexuality psychosexual effects of disease. New York: Macmillan; 1985. p. 231–239
  24. Tardif GS. Sexual activity after myocardial infarction. Arch Phys Med Rehabil. 1989;70:763–766[Web of Science][Medline]
  25. Papadopoulos C. Cardiovascular drugs and sexuality. Arch Intern Med. 1980;140:1341–1345[Abstract/Free Full Text]
  26. Wein AJ, Van Arsdalan KN. Drug-induced male sexual dysfunction. Urol Clin North Am. 1988;15:23–31[Web of Science][Medline]
  27. Bulpitt Cl, Dollery CT. Side-effects of hvpotensive agents evaluated by a self-administered questionnaire. Br Med J. 1973;3:485–490[Abstract/Free Full Text]
  28. Laver MC. Sexual behavior patterns in male hypertensives. Aust N Z J Med. 1974;4:29–31[Web of Science][Medline]
  29. Glazer N. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study. Curr Ther Res Clin Exp. 1975;17:249–256[Web of Science][Medline]
  30. Bauer GE, Hull RD, Stokes GS, Raftos J. The reversibility of side effects of guanethidine therapy. Med J Aust. 1973;1:930–933[Web of Science][Medline]
  31. Product Information: Corgard(R), nadolol, Princeton, NJ, Bristol Laboratories, 1996
  32. Smith PJ, Talbert RL. Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm. 1986;5:373–384[Web of Science][Medline]
  33. Stokes GS, Mennie BA, Gellatly R, Hill A. On the combination of alpha- and beta-adrenoceptor blockade in hypertension. Clin Pharmacol Ther. 1983;34:576–582[Web of Science][Medline]
  34. Osborne DR. Propranolol and Peyronie's disease. Lancet. 1977;i:111[CrossRef]
  35. Wallis AA, Bell R, Sutherland PW. Propranolol and Peyronie's disease. Lancet. 1977;1:980[Web of Science][Medline]
  36. Product Information: Lopressor(R), metoprolol, East Hanover, NJ, Novartis Pharmaceutical, 1998
  37. Product Information: Toprol XL(R), metoprolol succinate, Westborough, MA, Astra USA, 1998
  38. Yudkin JS. Peyronie's disease in association with metoprolol. Lancet. 1977;ii:1355
  39. Michelson EL, Frishman WH, Lewis JE. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med. 1983;75:68–80[Web of Science][Medline]
  40. Abramowicz M. Drugs that cause sexual dysfunction. Med Lett Drugs Ther. 1987;29:65–70[Web of Science][Medline]
  41. Law MR, Copland RF, Armitstead JG. Labetalol and priapism. Br Med J. 1980;280:115[Free Full Text]
  42. Product Information: Norpace(R), disopyramide immediate-release and controlled-release capsules, Skokie, IL, GD Searle & Company, 1998
  43. Ahmad S. Amiodarone and sexual dysfunction. Am Heart J. 1995;130:1320–1321[CrossRef][Web of Science][Medline]
  44. Gentzkow GD, Sullivan JY. Extracardiac adverse effects of flecainide. Am J Cardiol. 1984;53:101B–105B[CrossRef][Medline]
  45. Product Information: Mexitil(R), mexiletine, Ridgefield, CT, Boehringer Ingelheim, 1998
  46. Product Information: Rythmol(R), propafenone, Whippany, NJ, Knoll Pharmaceuticals, 1998
  47. Product Information: Betapace(R), sotalol HCl, Wayne, NJ, Berlex Laboratories, 1998
  48. Singh BN, Deedwania P, Nademanee K, Ward A, Sorkin EM. Sotalol: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs. 1987;34:311–349[Web of Science][Medline]
  49. Carvajal A, Lerida MT, Sanchez A, Martin LH, de Diego IM. ACE inhibitors and impotence; a case series from the Spanish drug monitoring system. Drug Saf. 1995;13:130–131[Web of Science][Medline]
  50. Product Information: Cozaar(R), losartan, West Point, PA, Merck & Co, Inc, 1998
  51. Product Information: Diovan(R), valsartan, Summit, NJ, Ciba-Geigy, 1998
  52. Pizarro S, Bargay J, D'Agosto P. Gemfibrozil-induced impotence (letter). Lancet. 1990;336:1135[Web of Science][Medline]
  53. Bain SC, Lemon M, Jones AF. Gemfibrozil-induced impotence (letter). Lancet. 1990;336:1389[Web of Science][Medline]
  54. J Am Med Assoc. 1993;270:83–90[Abstract/Free Full Text]
  55. Kloner RA, Jarow JP. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Cardiol. 1999;83:576–582[CrossRef][Web of Science][Medline]
  56. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates: results of the Massachusetts male aging study. J Urol. 1994;151:54–61[Web of Science][Medline]
  57. Burnett A. Erectile dysfunction: a practical approach for primary care. Geriatrics. 1998;53:34–48
  58. Dewire DM. Evaluation and treatment of erectile dysfunction. Am Fam Physician. 1996;53:2101–2106[Web of Science][Medline]
  59. Ernst E, Pitteler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998;159:433–436[CrossRef][Web of Science][Medline]
  60. Padma-Nathan H, Hellstrom WJG, Kaiser FE. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336:1–7[Abstract/Free Full Text]
  61. Kaplan, SA, Reis, RB, Kohn, IJ, Safety and efficacy of sildenafil in postmenopausal woman with sexual dysfunction. Urology, 1999, 53, 481, 6
  62. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334:873–877[Abstract/Free Full Text]
  63. Vaidyanathan S, Soni BM, Krishnan KR. Special precautions to be observed while using alprostadil in patients with spinal cord injury. Spinal Cord. 1997;35:402–403[CrossRef][Web of Science][Medline]
  64. Cheitlin MD, Hutter AM Jr, Brindis RG. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol. 1999;33:273–282[Free Full Text]
  65. Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 1999;83:13C–20C[Web of Science][Medline]
  66. Webb, DJ, Freestone, S, Allen, MJ, Muirhead, GJ, Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction and a calcium antagonist, Am J Cardiol 1999, 83, 21C, 28C
  67. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am J Cardiol. 1999;83:29C–34C
  68. Food and Drug Administration Web site, Postmarketing safety of sildenafil citrate (viagra), http://www.fda.gov/cder/consumerinfo/viagra/safety3.htm
  69. Zusman RM, Morales AA, Glasser DB, Osterloh LH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol. 1999;83:35C–44C[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
E. Erdmann
Safety and tolerability of beta-blockers: prejudices and reality
Eur. Heart J. Suppl., March 1, 2009; 11(suppl_A): A21 - A25.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rerkpattanapipat, P
Right arrow Articles by Kotler, M.N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rerkpattanapipat, P
Right arrow Articles by Kotler, M.N
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?